It looks like you are using an older version of Internet Explorer which is not supported. We advise that you update your browser to the latest version of Microsoft Edge, or
consider using other browsers such as Chrome, Firefox or Safari.
Iʼm an OmniSource Case Manager and Iʼm here to help get you enrolled on OmniSource, to welcome you to the program, and to support along the way.
To get started, Iʼll work closely with your doctor throughout the onboarding process – helping with Benefits Investigation (BI) and Prior Authorization (PA) forms and any potential appeals.
Once youʼre enrolled, Iʼll work with you to explain all of the OmniSource services available to you and your family, and help you determine which which options are best for you.
Itʼs my job to support you make the most of your treatment journey, so if you have any questions along the way, you know who to ask!
Iʼm an OmniSource Nurse Trainer and itʼs my role to help you get as comfortable as possible with administering your treatment at home.
I know that getting used to an injection routine can be challenging. Thatʼs why Iʼm here to help you and your family to learn how to inject as safely as possible, at a pace that works for you.
There are three ways that we can work together. I offer injection training in person at your home, over the telephone or by video chat – however you are most comfortable.
If at any point, you would like a refresher or some additional training, call your OmniSource Case Manager and they will be able to look into whether a Nurse Trainer is available.
Omnitrope is a recombinant human growth hormone indicated for:
Pediatric: Treatment of children with growth failure due to growth hormone deficiency (GHD), Prader-Willi Syndrome, Small for Gestational Age, Turner Syndrome, and Idiopathic Short Stature
Adult: Treatment of adults with either adult onset or childhood onset GHD
Who should not take Omnitrope?
Omnitrope should not be used in children and adults with any of the following medical conditions because serious side effects, including death, can occur:
a critical illness caused by certain types of heart or stomach surgery, serious injury or a sudden and severe breathing problem (respiratory failure)
Prader-Willi syndrome patients who are severely overweight or have a history of breathing problems including sleep apnea
cancer or other tumors
allergies to growth hormone or any of the ingredients in the medicine
certain types of eye problems caused by diabetes
Omnitrope should also not be used in children who have completed growth
What should patients tell their doctor before taking Omnitrope?
Patients should tell their doctor about their medical and family history, treatment use and past and existing medical conditions, such as - but not limited to - the following:
cancer or any tumor
use of prescription and non-prescription medicines, steroids, vitamins, and herbal supplements
What are the most common side effects of Omnitrope?
local reactions at the injection site (such as pain, numbness, redness and swelling)
swelling associated with fluid retention
pain in joints and muscle pain
carpal tunnel syndrome
tingling and numbness
high blood sugar (hyperglycemia/diabetes) and sugar in urine (glucosuria)
unusual skin sensations
low levels of thyroid hormone (hypothyroidism)
Other possible side effects of Omnitrope are:
return of tumor or cancerous growths
headaches, changes in vision, nausea or vomiting (these may be symptoms of raised pressure in the brain which requires immediate medical attention)
hip and knee pain or a limp in children, which can be a sign of slipped capital femoral epiphysis
worsening of pre-existing curvature of the spine in children (scoliosis)
increased ear infections and ear disorders in children with Turner syndrome; check for cardiovascular disorders (hypertension, stroke)
intense pain and tenderness in the abdomen as consequence of an inflammation of the pancreas (pancreatitis)
gasping syndrome (decreased rate of breathing) in children from high levels of benzyl alcohol (an inactive ingredient)
Increased mortality in patients with Prader Willi and acute illness
Please see full Prescribing Information for Omnitrope.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. To report SUSPECTED ADVERSE REACTIONS, contact Sandoz Inc. at 1-800-525-8747 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.